Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ... This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an FDA-approved medication for people who have type 2 diabetes.

Understanding the Context

It’s often prescribed “off-label” for weight loss — when a ... MSN: Just taking Ozempic won't help with weight loss, daily exercise still matters: New study warns Weight-loss medications like GLP-1 receptor agonists have transformed obesity care in recent years by helping millions reduce appetite and shed excess weight. These drugs like Ozempic, Wegovy and ... Just taking Ozempic won't help with weight loss, daily exercise still matters: New study warns WPXI: FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side effects of the drugs.

Key Insights

The agency told Novo Nordisk it had “serious ... FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects